LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Torin1 | 0.04 | uM | LJP6 | 3 | O18 | 72 | hr | 929 | 1388 | 3228 | 0.4300 | 0.1996 |
Hs 578T | Torin2 | 0.04 | uM | LJP5 | 1 | I24 | 72 | hr | 929 | 1328 | 3228 | 0.4114 | 0.1735 |
Hs 578T | Torin2 | 0.04 | uM | LJP5 | 2 | I24 | 72 | hr | 929 | 1442 | 3228 | 0.4467 | 0.2231 |
Hs 578T | Torin2 | 0.04 | uM | LJP5 | 3 | I24 | 72 | hr | 929 | 1440 | 3228 | 0.4461 | 0.2222 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 929 | 1365 | 3228 | 0.4229 | 0.1896 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 929 | 1375 | 3228 | 0.4260 | 0.1939 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 929 | 1457 | 3228 | 0.4514 | 0.2296 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 929 | 1519 | 3228 | 0.4706 | 0.2566 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 929 | 1472 | 3228 | 0.4560 | 0.2361 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 929 | 1586 | 3228 | 0.4913 | 0.2857 |
Hs 578T | TWS119 | 0.04 | uM | LJP5 | 1 | M06 | 72 | hr | 929 | 3212 | 3228 | 0.9950 | 0.9930 |
Hs 578T | TWS119 | 0.04 | uM | LJP5 | 2 | M06 | 72 | hr | 929 | 3264 | 3228 | 1.0111 | 1.0156 |
Hs 578T | TWS119 | 0.04 | uM | LJP5 | 3 | M06 | 72 | hr | 929 | 3427 | 3228 | 1.0616 | 1.0865 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 929 | 3283 | 3228 | 1.0170 | 1.0239 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 929 | 3295 | 3228 | 1.0207 | 1.0291 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 929 | 3373 | 3228 | 1.0449 | 1.0630 |
Hs 578T | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 929 | 3186 | 3228 | 0.9870 | 0.9817 |
Hs 578T | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 929 | 3239 | 3228 | 1.0034 | 1.0048 |
Hs 578T | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 929 | 3256 | 3228 | 1.0087 | 1.0122 |
Hs 578T | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 929 | 3266 | 3228 | 1.0118 | 1.0165 |
Hs 578T | Withaferin A | 0.04 | uM | LJP6 | 2 | G18 | 72 | hr | 929 | 3181 | 3228 | 0.9854 | 0.9795 |
Hs 578T | Withaferin A | 0.04 | uM | LJP6 | 3 | G18 | 72 | hr | 929 | 3257 | 3228 | 1.0090 | 1.0126 |
Hs 578T | WYE-125132 | 0.04 | uM | LJP6 | 1 | L12 | 72 | hr | 929 | 1385 | 3228 | 0.4291 | 0.1983 |
Hs 578T | WYE-125132 | 0.04 | uM | LJP6 | 2 | L12 | 72 | hr | 929 | 1398 | 3228 | 0.4331 | 0.2039 |
Hs 578T | WYE-125132 | 0.04 | uM | LJP6 | 3 | L12 | 72 | hr | 929 | 1485 | 3228 | 0.4600 | 0.2418 |